Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40.0Revenue $M--Net Margin (%)--Altman Z-Score1.7
Enterprise Value $M-4.3EPS $-0.6Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio17.8Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-34.5Current Ratio17.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-65.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-73.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M62.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BIOD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIODDavid Swensen 2010-12-31 Sold Out $6.44 - $19.08
($10.17)
$ 0.64-94%Sold Out0
BIODDavid Swensen 2009-12-31 Buy 11.73%$14.16 - $21.04
($17.18)
$ 0.64-96%New holding225,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIOD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIOD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pereira Brian JGDirector 2013-12-20Sell4,734$2.26-71.68 view
LIEBERMAN IRADirector 2013-12-20Buy10,800$2.29-72.05 view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-12-07Sell12,256$2.8-77.14 view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-11-02Sell3,500$2.81-77.22 view
Krasner Alan SethChief Medical Officer 2012-11-02Sell3,500$2.81-77.22 view
DESOUZA ERROL BCEO 2012-09-20Buy10,000$3.34-80.84 view
Bavier Paul SGeneral Counsel/Corp. Sec. 2012-03-13Sell2,096$2.36-72.88 view
Pereira Brian JGDirector 2011-12-16Sell3,750$2.6-75.38 view
Steiner SolomonDirector 2011-09-26Sell32,695$4.36-85.32 view
Steiner SolomonDirector 2011-09-21Sell79,129$4.72-86.44 view

Quarterly/Annual Reports about BIOD:

News about BIOD:

Articles On GuruFocus.com
cooldecency99 note on BIOD May 01 2010 
Biodel Reports Third Quarter Fiscal Year 2009 Financial Results Aug 07 2009 
Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009 Aug 03 2009 
Biodel Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update Feb 05 2009 
Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study Jan 30 2009 
Biodel Inc. Reports Fourth Quarter and Fiscal Year 2008 Financial Results Dec 10 2008 

More From Other Websites
BIODEL INC Financials Aug 27 2015
10-Q for Biodel, Inc. Aug 16 2015
BIODEL INC Files SEC form 10-Q, Quarterly Report Aug 14 2015
Edited Transcript of BIOD earnings conference call or presentation 13-Aug-15 9:00pm GMT Aug 14 2015
BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 13 2015
Biodel Reports Third Quarter Fiscal Year 2015 Financial Results Aug 13 2015
Q3 2015 Biodel Inc Earnings Release - 4:00 pm ET Aug 13 2015
Biodel to Report Third Quarter Fiscal Year 2015 Financial Results on August 13, 2015 Aug 06 2015
Edited Transcript of BIOD presentation 24-Jun-15 6:00pm GMT Jun 29 2015
Biodel to Present at Two Upcoming Investor Conferences Jun 18 2015
BIODEL INC Files SEC form 8-K/A, Change in Directors or Principal Officers Jun 08 2015
10-Q/A for Biodel, Inc. Jun 03 2015
BIODEL INC Files SEC form 10-Q/A, Quarterly Report Jun 01 2015
Biodel to Present Data on Concentrated Ultra-Rapid-Acting/Basal Insulin and Glucagon at the 75th... May 28 2015
BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... May 21 2015
Biodel Announces Phase 2b Clinical Trial Initiation of BIOD-531, the Company's Concentrated,... May 21 2015
Biodel Appoints Ms. Arlene M. Morris to Its Board of Directors May 18 2015
BIODEL INC Files SEC form 10-Q, Quarterly Report May 07 2015
BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 06 2015
Biodel Reports Second Quarter Fiscal Year 2015 Financial Results May 06 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK